Clinical Trial Update: Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

View source ↗

Summary

A completed real-world study comparing palbociclib plus an aromatase inhibitor versus an aromatase inhibitor alone in premenopausal patients with metastatic bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)
• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Breast Cancer | Status: COMPLETED | Results posted: 2024-10-08